Patent · US Active

IAP BIR domain binding compounds

US9284350B2 · kind B2 · utility

0Cited by
14References
39Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 11, 2011
Grant dateMar 15, 2016
Priority date
Expiry dateJun 7, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of Formula 1: (I) or salt thereof, as well as methods of making compounds of Formula 1, methods of using compounds of Formula 1 to treat proliferative disorders such as cancer, and related compounds, composition, and methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.